VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VYCOR MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
Vycor Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Market Cap | $2.24M | $230.55M |
| Enterprise Value | $2.21M | $202.97M |
| PS Ratio | 1.24 | 3.10 |
| P/OCF Ratio | 36.43 | 22.47 |
Enterprise value
| Measure | Vycor Medical | Industry median |
|---|---|---|
| EV / Sales | 1.22 | 2.91 |
| EV / EBITDA | 20.69 | 19.74 |
| EV / EBIT | 45.85 | 24.80 |
Income (trailing twelve months)
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Revenue | $1.81M | $102.39M |
| Gross Profit | $1.51M | $60.36M |
| Operating Income | $48.22K | -$4.31M |
| Pretax Income | -$56.40K | -$2.37M |
| Net Income | -$59.93K | -$6.57M |
| EBITDA | $106.84K | -$1.98M |
| EPS (Diluted) | $0.00 | -$0.08 |
Margins
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Gross Margin | 83.4% | 55.2% |
| Operating Margin | 2.67% | -6.04% |
| Pretax Margin | -3.12% | -4.11% |
| Profit Margin | -3.32% | -10.5% |
| EBITDA Margin | 5.91% | -2.67% |
Returns
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Return on Assets (ROA) | -7.08% | -13.3% |
Growth
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.61% | 8.85% |
| Revenue Growth (3Y CAGR) | 15.1% | 7.08% |
| Revenue Growth (5Y CAGR) | 10.3% | 11.8% |
Balance sheet
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $158.91K | $36.66M |
| Total Debt | $133.98K | $97.65M |
| Net Cash (Debt) | $24.93K | $3.92M |
| Net Cash Per Share | $0.00 | $0.28 |
| Equity (Book Value) | -$4.25M | $55.33M |
| Book Value Per Share | -$0.13 | $2.87 |
| Tangible Book Value | -$4.25M | $10.79M |
| Working Capital | -$4.29M | $56.72M |
Financial position
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Current Ratio | 0.13 | 2.48 |
| Quick Ratio | 0.07 | 1.53 |
| Debt / EBITDA | 1.25 | 2.40 |
| Net Debt / EBITDA | -0.23 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Operating Cash Flow | $61.38K | -$566.22K |
Efficiency
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Asset Turnover | 2.14 | 0.58 |
| Inventory Turnover | 1.73 | 2.21 |
| Revenue Per Employee | $258.21K | $322.92K |
| Profits Per Employee | -$8.56K | -$51.88K |
| Employee Count | 7 | 185 |
Dividends and yields
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Earnings Yield | -2.68% | -6.88% |
Shares
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Shares Outstanding | 33,372,800 | 44,302,700 |
| Shares Change (YoY) | -3.49% | 3.36% |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 33,372,800 | 37,462,700 |
| Shares Held by Insiders | 0.00% | 10.5% |
Scores
| Measure | Vycor Medical | Industry median |
|---|---|---|
| Altman Z-Score | -61.87 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -3 | -2.64 |
Calculated by StockData from Vycor Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.